Olfen Gel (Diclofenac Sodium)

Diclofenac sodium, the active ingredient in Olfen Gel, is a nonsteroidal anti-inflammatory drug (NSAID) presented as a topical gel for cutaneous use. It reduces inflammation and alleviates pain associated with musculoskeletal conditions, sports injuries, sprains, strains and arthritis in adults.

GNH USA supplies Olfen Gel as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies, and clinics worldwide for professional use. The company adheres to stringent quality assurance protocols and ensures regulatory compliance across EU and other markets.

Diclofenac sodium gel is a topical NSAID that acts on inflammatory pathways to relieve pain and swelling.

Musculoskeletal pain: provides localized pain relief at the application site. Sports injuries: reduces inflammation and supports faster recovery. Sprains and strains: alleviates swelling and discomfort. Arthritis: diminishes joint pain and stiffness.

Topical application of diclofenac sodium may cause local and systemic adverse reactions.

Common Side Effects: - Skin irritation at the site of application. - Redness or erythema. - Burning or stinging sensation. - Pruritus (itching). - Dryness of the skin. - Localized itching.

Serious or Rare Side Effects: - Allergic contact dermatitis. - Systemic NSAID effects such as gastrointestinal ulceration. - Elevated liver enzymes indicating hepatic involvement. - Severe skin reactions, including Stevens‑Johnson syndrome.

When using Olfen Gel, consider the following precautions.

Apply to intact skin: avoid broken or infected areas. Limit area of application: do not exceed 10% of body surface at one time. Avoid concurrent systemic NSAIDs: increased risk of systemic toxicity. Use with caution in patients with cardiovascular disease: monitor for edema. Pregnancy and lactation: consult a healthcare professional before use. Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Olfen Gel may interact with other medicines; review the following.

Major Interactions (Avoid): - Concurrent oral NSAIDs: heightened risk of systemic toxicity. - Anticoagulants (e.g., warfarin, DOACs): increased bleeding tendency. - Systemic corticosteroids: additive risk of gastrointestinal ulceration.

Moderate Interactions (Monitor Closely): - ACE inhibitors or diuretics: possible impact on renal function. - Lithium: potential rise in serum lithium levels. - Methotrexate: reduced clearance leading to toxicity.